chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore arm for the first 3 days following shot. Then around fourth day arm started to become red, swelled, and itchy. At the injection site arm feels like a hard knot which is warm and feverish from around day 4 up to current date of this report. I have taken tylenol, motrin,  zyrtec, benadryl, and applied ice.
Upon receiving Pfizer Bivalent, it was improperly stored in the freezer. This vaccine should have been stored in the refrigerator. Due to the incorrect storage patient received vaccine that was expired. NO ISSUES REPORTED.
Extreme exhaustion, Ecchymosis/ bruising Tinnitus, Headache,   sleeping for 15 hours for weeks, still having Exhaustion, Tinnitus, bruising
Vaccine was administered on 5/11/2021 but was expired as of 5/6/2021 according to 30 day rule. We received vaccine on 4/6/2021.
3/14/2021 admitted by ambulance to hospital with diagnosis of subarachnoid hemorrhage. EVD placed for brain bleed. VP shunt place 4/1/21.  No aneurysm found.  Multiple episodes of atrial fibrillation/flutter also  occurred during hospital stay. Discharged 4/2/21.  April-May 2021 multiple episodes of atrial fibrillation/flutter resulting in several visits and one hospital stay.
Patient received Pfizer Vaccine on 1/21/21 and returned to our clinic for his second dose.  Due to inclement weather, our clinic had to reschedule appointments from 2/11/21 including this patient who was put on the schedule for 2/10--the clinic for 2/10 was scheduled to be Moderna in the AM and Pfizer in the PM.  Unfortunately, we were still giving Moderna when he came and he was inadvertently given Moderna instead of Pfizer.
Pt requested vaccine preservative free. She received vaccine containing preservatives. Pt waited for 30 min. before leaving store. No ADRs reported.
Initially Fever, Irritability, Change from a quiet calm child to having tantrums. Waking up in middle of night when normally sleeps 11 hours straight. Over the span of 2 months she had random vomiting and diarrhea (2-6 times a week). After doing a foot zoning (ment to detox toxins in body) She starting swelling and getting rash, followed by vomiting. The swelling was really severe one night and made her face and lips swollen and was starting to go to her throat. We almost took her to ER but we were able to get the swelling to go down. We took her to doctor next day and he said she had hives like reaction to some allergy. I took her to a nutritionist who did a full body scan and He concluded that her nervous system, lymphatic system, connective tissue were severely stressed due to heavy metals in her system.
I originally got the J&J vaccine on 4/7/2021. The adverse reaction occurred after getting the Pfizer booster on 12/10/2021. I developed tinnitus in both ears that does not diminish, cannot be mitigated thus far.
A 43 year old female reported that she received a dose of Flu Shield '01-'02 vaccine on 12/10/01. Within 3 minutes, she experienced tingling and numbness in her arm which progressed to her face and left side, difficulty breathing, itching and vision was out of focus. At the date of the report, no further information was available. Tingling, numbness and difficulty breathing are considered "Medically Important Events". Follow-up information received from the vaccine administrator on 01/02/2002, stated that the paitent began to feel numb and tingly in the vaccinated arm as she was leaving the room where she was vaccinated. Then while en route home, she experienced the other symtoms as stated above and went directly to a physician for evaluation. The physician allegedly told the patient that he "didn't know for sure what caused her symptoms". The patient reported to the vaccine administrator that "it took four days for her symptoms to dissipate and for her to feel normal again.
MILD PAIN IN THE AREA OF APPLICATION; This spontaneous report received from a consumer concerned a 38 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A expiry: UNKNOWN) dose was not reported, administered on 26-MAY-2021 for prophylactic vaccination. No concomitant medications were reported.  On 26-MAY-2021, the subject experienced mild pain in the area of application. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of mild pain in the area of application was not reported. This report was non-serious. This case, from the same reporter is linked to 20210556038.
This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old male patient who received KINRIX (batch number KJ92, expiry date 22nd October 2015). On an unknown date, the patient received KINRIX (intramuscular) .5 ml. On an unknown date, the dose was an unknown dose. On an unknown date, an unknown time after receiving KINRIX, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional information: Office Manager reports that 2 month old child inadvertently received KINRIX vaccination. No other AE's were voiced. Caller was transferred to Medical Information Scientist as requested.
This spontaneous report was received from a medical assistant referring to a 75 year old female patient. The patient's concurrent condition, medical history and concomitant therapy were unknown. On 08-AUG-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # M018766 with expiration date: 15-OCT-2017; dose and route not reported), one time injection. On 09-AUG-2016, the patient experienced fever, red, hot, swollen and painful arm. The patient sought medical attention and unspecified treatments were given. At the time of reporting, the outcome of all events was unknown. Additional information has been requested.
Vaccine was administered at 8:12am.  At 8:15am, associate complained that throat was closing and that she was having difficulty breathing.  Vital signs were obtained; Heart Rate 135, spO2 was 98% on room air; blood pressure was not able to be obtained; associate used own inhaler prescribed for asthma and the associate was administered Benedryl 25mg p.o. in the observation area.  The associate was transfered to the Emergency Dept.  Prior to transfer to the ED, heart rate was 8:19 was 118 and the associate reported to be feeling better.
I was having pain on my lower right and left side of my abdomen. I went to a urologist for a CT scan which was normal other than a possible cyst on the left ovary. The pain persisted so I went to an OBGYN office and they identified a small complex tumor on the left ovary. They requested to remove the tumor and ovary within 1 week. I did have the surgery and the tumor was benign. I am not quite 6 weeks post op but still experiencing pain the left lower quadrant.
1 - 2 days after vaccines (including Rotateq) were administered, patient experienced an increased frequency of stool from 2 -3 a day to 8 - 10 a day with mucus.
Pt started with complaints of arms hurting badly, stiff neck, weakness, paleness and heaviness in his chest. He was given NSAIDS as needed. He was checked by nurse at Health Center. He had intermittent fever and complaints over three days, but then had one day of improvement. However on 07/12/15 he woke up with hives and difficulty breathing. He was taken to urgent care and prescribed prednisone and Benadryl use every 4 hours. The next day, he developed worsening of hives into welts with sensation of "burning up inside". His tongue became hot, red and swollen. He was taken to ER and given epinephrine shot and monitored. He was able to be released, but symptoms worsened again later in the day. The doctor was contacted and prescribed Allegra in addition to Benadryl and prednisone as well as increased fluids. Symptoms came intermittently over next few days with hives appearing to move around his body, but he had no further difficulty with his breathing.
2 weeks after, I developed spontaneous urticaria; identical to the case study detailed here in a case study.
Pt walked into the clinic and asked to see the RN explained received shots yesterday. Left deltoid area hard, redden rash. Pt states she woke up left arm noticed it was much larger, but she had been moving her arm, it has decreased in size by 50%. Redden area measured 8 cm (marked with purple marker. Anterior area red rash was 13 x 13 cm. Pt states she felt feverish 10/30/17 but didn't take her temperature. Warm compresses and symptomatic support given ED precautions. Given return precautions, will call RN in our office with concerns if they arise. Given abx precautions. Vaccine updated as allergy for PT, RN to report VAERS. 11/1 Telephone call to daughter who states left arm is much better, little redness, swelling much reduced.
p/vax pt T102-105;c/o pelvic/joint pain & sluggishness cont until 8/23/99;pt taken to MD for eval;grandma stated child better a/going to MD & MD could find nothing wrong w/child;family told to return to MD if any s/s returned;
Went home, at 7:00pm I had dinner but the next I felt tired.  Got COVID on April 9, 2022. April 4, I went for a dental work but I was fine abut I night I had Thor throat and I had the home COVID test - it was positive.
Pt developed a large sterile cellulitis, 6 X 6 inches in size, red, warm to touch over left thigh after Prevnar injection.
Starting within 24 hours after shot pt experienced a "huge outflow of mucous"; no fever & no other symptoms; pt. came back 1 week after shot to report symptoms and RPh did not seem to think vaccine related; pt. as of 1/23/13 still some mucous.
pt came in today to receive another vaccine and when pulling up vaccine history we noticed she received 2 prevnar 13 (in 2017 and 2018)
Client c/o feeling dizzy and having stomachache approx 1 hr. and 35 mins. after receiving vaccine. BP 120/74 & 110/80. Mother noticed - home with mom referred to PMD. Follow up telephone call doing very well per mother.
No discomfort with the shot itself, the reaction was the diarrhea that lasted 8-9 days and I tried over the counter things to help. I have an auto immune issue and the vaccine may have triggered what happened.
passed out because she was feeling that the world was revolving; shortness of breath when she moves; fast heart beat when she moves; swelling in right leg; Numbness in right leg; body ache; fever; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (passed out because she was feeling that the world was revolving) and DYSPNOEA EXERTIONAL (shortness of breath when she moves) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 28-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN (body ache) and PYREXIA (fever). On an unknown date, the patient experienced LOSS OF CONSCIOUSNESS (passed out because she was feeling that the world was revolving) (seriousness criterion medically significant), DYSPNOEA EXERTIONAL (shortness of breath when she moves) (seriousness criterion medically significant), HEART RATE INCREASED (fast heart beat when she moves), PERIPHERAL SWELLING (swelling in right leg) and HYPOAESTHESIA (Numbness in right leg). On 29-Mar-2021, PAIN (body ache) and PYREXIA (fever) had resolved. At the time of the report, LOSS OF CONSCIOUSNESS (passed out because she was feeling that the world was revolving), DYSPNOEA EXERTIONAL (shortness of breath when she moves), HEART RATE INCREASED (fast heart beat when she moves), PERIPHERAL SWELLING (swelling in right leg) and HYPOAESTHESIA (Numbness in right leg) outcome was unknown.            No concomitant medication were not provided.  The patient was treated with PARACETAMOL (TYLENOL) and METOPROLOL.  Action taken with mRNA-1273 in response to the event was not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
On May 1, I developed some symptoms including skin that was sensitive to the touch and was sore/painful and chills. The next day on May 2, I developed a headache, fever, fatigue and some body aches while maintaining the sensitive skin and chills. On May 3, I developed an itchy and red rash on my skin, which I experienced during the first dosage.
She has had normal periods every month.  Had the first dose of the vaccine in August.  She had one menstrual cycle after that in early September (this was a normal period).  After the second dose on 9/20, her periods stopped. Now it has been more than two months and she still hasn't had a period.
This spontaneous case, initially received on 08-Sep-2016, was reported by a Non-Health Professional and concerns a 42-year-old female patient. Weight: not provided; Height: not provided. Administration of company suspect drug(s): The patient received AFLURIA on 08-SEP-2016. Dose: 0.5 ml, Route of administration: Intramuscular. Batch number: 13049221A. No additional suspect drugs. Adverse reactions/events and outcomes: On 08-Sep-2016, the vaccine has been administered that had particles in the vials - no adverse event (outcome: unknown, special circumstances: poor quality drug administered).
Type 1 diabetic on an insulin pump.  Diabetes is well managed with a typical blood glucose level of 110.  BG has been in 300s since 6pm 7/3/21. Insulin administration is not able to bring it down. As of 10:30am 7/4 BG is still holding steady at 302 with no food eaten and 3x the usual daily amount of insulin given in the last 12 hours.  We are not administering more at this time due to the possibility of BG dropping exponentially once the side effect wears off.   Patient also experienced an unexpected low BG of 35 at around 4pm 7/3.
So sick for days; generalized weakness; fever; headache; shivering; This spontaneous case was reported by a nurse and describes the occurrence of ILLNESS (So sick for days), ASTHENIA (generalized weakness), PYREXIA (fever), HEADACHE (headache) and CHILLS (shivering) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     The patient's past medical history included DVT (4 years ago but hasn't been taking blood thinners or presented any symptoms since) and First pregnancy (4 years ago). Concomitant products included VITAMIN C [ASCORBIC ACID] and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 29-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jun-2021, the patient experienced ILLNESS (So sick for days), ASTHENIA (generalized weakness), PYREXIA (fever), HEADACHE (headache) and CHILLS (shivering). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 01-Jul-2021, ILLNESS (So sick for days), ASTHENIA (generalized weakness), PYREXIA (fever), HEADACHE (headache) and CHILLS (shivering) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-303289 (Patient Link).
Pt was given the COVID-19  Bivalent 3rd dose vaccine. Pt should have received the second vaccine in the primary series.
Narrative:  85 y/o male w/ PMH of essential hypertension, dementia with cognitive impairment, recently diagnosed adrenal incidentaloma, BPH, sickle cell trait, and glaucoma. Pt presented to ED on 06/08/22 w/ increased confusion after he has his allergy shot from community clinic that morning and noted generally weak upon going back home. Pt w/ afib RVR, nasal congestion, cough, fever and positive for COVID 19 and admitted to hospital. Chest X-ray negative for infiltrates. Pt treated with remdesivir (06/08-06/10). Pt also treated for chronic hypertension, chronic BPH , PVRs x 1 high now normal on Tamsulosin, chronic vitamin D deficiency, chronic unspecified glaucoma both eyes, chronic allergic rhinitis, acute hypokalemia and mild Thrombocytopenia due to COVID syndrome most likely. Pt improved and discharged to home on 06/14.
Had Grand Mal seizure about 1 hour after receiving Pneumovax. The seizure reportedly lasted about 5 minutes. He suffered a laceration over his right eyebrow and was admitted to the hospital.
Joint pain; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain), PYREXIA (Fever) and HEADACHE (Headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included FLUTICASONE for an unknown indication.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced ARTHRALGIA (Joint pain), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, ARTHRALGIA (Joint pain), PYREXIA (Fever) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details reported.
Very sore right arm radiating under my arm, neck, and right breast area.  Very tender to palpate lymph nodes under right arm and neck.  Tender right breast as well.  Symptoms from the first night after the second vaccine and still 13 days later.
The day after the joint I had severe joint aches. I had to take some Tylenol. The day after the pain was better but I got a burning rash in both armpits. It was not raised and burned on the right side more. It was a solid area in my entire armpit and very red. I had no soreness around the vaccine site. I used steroid cream and took 50mg of Benadryl. Two days later it was gone.
swollen arm area and red rash, low grade fever 99.5, nausea, chills,
vaginal bleeding; She has been having nausea; Feels hungry; she has intestinal issues here and there which is unusual for her; stomach feels queasy; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 59-years-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number: not reported/Lot Number: ER8732), via an unspecified route of administration, administered in Arm Left on 03Jun2021 (Age at vaccination 59-years-old), as dose 2, single for COVID-19 immunization. Medical history included muscle strain from an unknown date and unknown if ongoing. Concomitant medications included ibuprofen (IBUPROFEN) taken for muscle strain start and stop date were not reported. The patient previously received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number: not reported/Lot Number: ER8735), via an unspecified route of administration, administered in Arm Left on 13May2021 (Age at vaccination 59-years-old), as dose 1, single for covid-19 immunization. In Jun2021, the patient was feels hungry, she had intestinal issues here and there which was unusual for her, stomach feels queasy. On 14Jun2021, the patient had been having nausea. On 21Jun2021, the patient experienced vaginal bleeding. Caller was calling about the Pfizer Covid-19 Vaccine. She wanted to call to see if some of the symptoms she was having has anything to do with the Covid shot. She does not know if they can or could not. This was unusual for her. She had been having nausea. She was fine but then it was after the last vaccination. 03Jun2021 was her second one. It was not at first and she was fine. It started the week of 14Jun2021 so about a week and a half after her shot. She started feeling nauseous and that is not usual for her. On 21Jun2021 she started having vaginal bleeding which she had not had in years. Just the one day. Nausea, she was still having today. It was about the same. It comes and goes and she still feels hungry but her stomach feels queasy and she has intestinal issues here and there which is unusual for her. Caller stated that was all of her symptoms and she did not know if she should call or if she should not but she thought she would call just to see. No treatment was received for the events. Clinical outcome of the events She has been having nausea, feels hungry was not recovered. Outcome of the event vaginal bleeding was recovered on 21Jun2021. Outcome of the events she has intestinal issues here and there which was unusual for her and stomach feels queasy was unknown.  Follow-up attempts are completed. No further information is expected.
Patient received a dose of Pfizer COVID-19Vaccine  Peds formulation (5-11yr) that may have been reconstituted with a single use vial of 0.9%NS that was entered into multiple times to reconstitute other vials of Pfizer vaccine. Staff did not realize the 10mL vial  was for single use only (to take out 1.3mL then discard). Each time the vial was used it was swabbed with alcohol and a new syringe was used to enter the vial then to add the diluent to the Pfizer vaccine for reconstitution. The 10mL ,  0.9%NS vial was disposed of at the end of each day. The patient did not experience any adverse reaction. At the recommendation of Pfizer and the CDC, due to lack of stability data, it was advised to revaccinate the patient.
Initial information received on 22-Oct-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 78 years old female patient who experienced chronic pain at the injection site, while she received vaccine FLUZONE HIGH DOSE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE lot number not reported via intramuscular route in the deltoid. On an unknown date, the patient developed a non-serious chronic pain at the injection site (vaccination site pain) (Unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE. (Other relevant tests included no lab data). Final diagnosis was chronic pain at the injection site. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for chronic pain at the injection site. List of documents held by sender: none.
flushing of face & head getting dazed, trembling of arms; p/episode would fall asleep; given Phenobarb injec-stopped "spells";
This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (may have received 2 doses of Moderna at 9 years old) in a 9-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.  No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (may have received 2 doses of Moderna at 9 years old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (may have received 2 doses of Moderna at 9 years old) outcome was unknown. Concomitant medications was not provided by the reporter. Treatment information was not provided.